Rehospitalisation after birth hospitalisation: patterns among infants of all gestations.

Kaiser Permanente Medical Care Program, Division of Research, Perinatal Research Unit, 2000 Broadway, 2nd floor, Oakland, CA 94612, USA.
Archives of Disease in Childhood (Impact Factor: 2.91). 03/2005; 90(2):125-31. DOI: 10.1136/adc.2003.039974
Source: PubMed

ABSTRACT To analyse rehospitalisation of newborns of all gestations.
A total of 33,276 surviving infants of all gestations born between 1 October 1998 and 31 March 2000 at seven Kaiser Permanente Medical Care Program (KPMCP) delivery services were studied retrospectively.
Rehospitalisation rates within two weeks after nursery discharge ranged from 1.0% to 3.7%. The most common reason for rehospitalisation was jaundice. Among babies > or =34 weeks, the most important factor with respect to rehospitalisation was use of home phototherapy. Among babies who were not rehospitalised for jaundice, African-American race (adjusted odds ratio (AOR) = 0.56), and having a scheduled outpatient visit (AOR = 0.73) or a home visit (AOR = 0.59) within 72 hours after discharge were protective. Factors associated with increased risk were: being small for gestational age (AOR = 1.83), gestational age of 34-36 weeks without admission to the neonatal intensive care unit (AOR = 1.65), Score for Neonatal Acute Physiology, version II, > or =10 (AOR = 1.95), male gender (AOR = 1.24), having both a home as well as a clinic visit within 72 hours after discharge (AOR = 1.84), and birth facility (range of AORs = 1.52-2.36). Asian race was associated with rehospitalisation (AOR = 1.49) when all hospitalisations were considered, but this association did not persist if hospitalisations for jaundice were excluded.
In this insured population with access to integrated care, rehospitalisation rates for jaundice were strongly affected by availability of home phototherapy and by follow up. For other causes, moderate prematurity and follow up visits played a large role, but variation between centres persisted even after controlling for multiple factors. Future research should include development of better process measures for evaluation of follow up strategies.

  • [Show abstract] [Hide abstract]
    ABSTRACT: En los últimos años se ha incrementado considerablemente en el mundo el número de nacidos pretérmino (< 37 semanas). El avance en las terapias prenatal (corticoides) y posnatal (surfactante) ha contribuido a mejorar sensiblemente el pronóstico de estos niños. Como consecuencia de ello, los obstetras estamos desplazando con cierta inconsciencia la barrera de la prematuridad a la 34.a semana de gestación, con el consiguiente incremento de la prematuridad iatrogénica no siempre valorada en su justa medida.En ocasiones olvidamos que el embarazo en la especie humana dura como media 40 semanas y que, a lo largo de todo este periodo, se está produciendo el desarrollo morfológico y funcional de todos los órganos. Este proceso no finaliza en la semana 34.a, ni siquiera en la 37.a. Es cierto que esta maduración puede alcanzarse extrauterinamente pero está demostrado que ello no se produce de igual modo que dentro del seno materno.Debemos ser conscientes y actuar en consecuencia, ya que estos nacidos prematuros de más de 34 semanas, incluso los nacidos entre las 37.a y 39.a semanas, presentan morbilidad significativa, e incluso tienen incrementada la mortalidad perinatal.
    Progresos de Obstetricia y Ginecología 02/2012; 55(2):94-99.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The National Hospital of Pediatrics in Vietnam performed >200 exchange transfusions annually (2006-08), often on infants presenting encephalopathic from lower-level hospitals. As factors delaying care-seeking are not known, we sought to study care practices and traditional beliefs relating to neonatal jaundice in northern Vietnam.
    BMC Pediatrics 10/2014; 14(1):264. · 1.92 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Neonatal jaundice is caused by high levels of unconjugated bilirubin. It is usually a temporary condition due to delayed induction of Ugt1a1, which conjugates bilirubin in the liver. To reduce bilirubin levels, affected babies are exposed to phototherapy (PT), which converts toxic bilirubin into water-soluble photoisomers, readily excreted out. However, in some cases uncontrolled hyperbilirubinemia leads to neurotoxicity. To study the mechanisms of bilirubin-induced neurological damage (BIND) in vivo we generated a mouse model lacking the Ugt1a1 protein and, consequently, mutant mice developed jaundice as early as 36 h after birth. The mutation was transferred into two genetic backgrounds (C57Bl/6 and FVB/NJ). We exposed mutant mice to PT for different periods and analyzed the resulting phenotypes from the molecular, histological and behavioral points of view. Severity of BIND was associated with the genetic background, with 50% survival of C57Bl/6-Ugt1(-/-) mutant mice at postnatal day 5 (P5) and at P11 for FVB/NJ-Ugt1(-/-) mice. Life-long exposure to PT prevented cerebellar architecture alterations and rescued neuronal damage in FVB/NJ-Ugt1(-/-) mice, but not in C57Bl/6 ones. Survival of FVB/NJ-Ugt1(-/-) mice was directly related to the extent of PT treatment. PT treatment of FVB/NJ-Ugt1(-/-) mice from P0 to P8 did not prevent bilirubin-induced reduction in dendritic arborization and spine density of Purkinje cells. Moreover, PT treatment from P8 to P20 did not rescue bilirubin-induced neurological damage accumulated up to P8. However, PT treatment administered in the time-window P0-P15 was sufficient to obtain full rescue of cerebellar damage and motor impairment in FVB/NJ-Ugt1(-/-) mice. The possibility to modulate the severity of the phenotype by PT makes the FVB/NJ-Ugt1(-/-) mice an excellent and versatile model to study bilirubin neurotoxicity, the role of modifier genes, alternative therapies and cerebellar development during high-bilirubin conditions.
    Disease Models and Mechanisms 07/2014; · 5.54 Impact Factor

Full-text (2 Sources)

Available from
Feb 10, 2015